RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Casdin Capital, LLC's Holding History (CIK: 0001534261)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 165,323 Value ($000) $676 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 165,323 Value ($000) $807 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 165,323 Value ($000) $837 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 165,323 Value ($000) $875 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 165,323 Value ($000) $1,118 Avg Close $6.72 Range $5.60 - $9.55
Q1 2022
Shares 548,156 Value ($000) $3,925 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 548,156 Value ($000) $9,390 Avg Close $18.82 Range $15.25 - $23.86
Q3 2021
Shares 548,156 Value ($000) $12,613 Avg Close $28.34 Range $17.80 - $42.81
Q2 2021
Shares 548,156 Value ($000) $20,008 Avg Close $29.60 Range $19.68 - $38.39